Deerland Probiotics & Enzymes Hires Vice President of Sales-Americas, Expands Executive Team

KENNESAW, GA (November 18, 2020) – Deerland Probiotics and Enzymes has announced the hiring of a new vice president of sales-Americas as well as the creation of a new executive level position for product development and supply chain.

Michelle Cook has been named the company’s vice president of sales for the Americas region. Cook brings more than 25 years of experience leading sales teams in the OTC pharmaceutical and dietary supplement industries, most recently with DuPont Nutrition & Biosciences. She will oversee Deerland’s team of business development managers as they serve customers across the dietary supplement, food and beverage and pet nutrition industries.

With the addition of Michelle Cook as vice president of sales, Tod Burgess, who previously held the position for more than 20 years, has moved into the newly created role of vice president of product development and supply chain.  In this role, Burgess’s expertise will be harnessed to optimize the up-front product development process and supply chain continuity.

Scott Ravech, CEO, comments, “The addition of Michelle Cook to our staff along with Tod’s new role as vice president of product development and supply chain position demonstrates Deerland’s commitment to placing the best people in critical roles in order to provide maximum value for our customers.”

Deerland Probiotics & Enzymes, based in Kennesaw, Ga., specializes in developing science-backed solutions that benefit microbiome health, using probiotic, prebiotic and enzyme technology.  The company offers a line of unique, clinically validated branded products, including DE111®, PreforPro®, ProHydrolase®, Solarplast®, Glutalytic® and Bifolac® probiotic strains.  Deerland collaborates with customers to develop innovative and often proprietary solutions in the dietary supplement, food and beverage, sports nutrition, and companion animal markets. In addition to branded ingredients and customized formulations, Deerland offers full turnkey products for private label through its YourBrand® portfolio.  The company’s manufacturing services include bulk blends, capsules, stick packs and tablets, as well as bottling and labeling. To contact Deerland Probiotics & Enzymes, call 800.697.8179 or visit www.deerland.com.

Follow us on social media for the latest updates in B2B!

Image

Latest

Radar
Physical Retail’s Next Infrastructure Layer: Item-Level Intelligence with Radar
June 4, 2026

Physical retail is under pressure to become as measurable and responsive as e-commerce. While retailers have spent years optimizing digital channels with real-time data, store teams have often had to make decisions with incomplete inventory visibility and delayed operational signals. That gap matters because stores still account for 80% of U.S. retail sales, making…

Read More
Healthcare in Pakistan
From Institutional Excellence to Population-Level Access: How Pakistan Can Bridge Its Healthcare Divide
June 1, 2026

Healthcare systems are under pressure almost everywhere, but the strain is especially visible in lower-resource settings where demand is rising faster than infrastructure. In Pakistan, that pressure is playing out across a system that has to serve more than 250 million people with limited public investment. Public health spending remains below 1% of GDP,…

Read More
Engineering
Scaling Experiential Learning in the Curriculum: How Iron Range Engineering Transformed Engineering Education
June 1, 2026

Engineering has transformed nearly every part of modern life, from the phones in our pockets to the systems powering global industry. But the way engineers are educated has often moved far more slowly than the profession itself. Employers are asking for graduates who can navigate ambiguity, communicate across teams, and contribute meaningfully from the…

Read More
vascular surgeon
When Geography Meets Purpose: How One Move Reshaped a Vascular Surgeon’s Career
May 28, 2026

Medicine isn’t what it used to be—not for the people practicing it. Independent physicians are becoming the exception, not the norm, as more doctors move into hospital systems, corporate groups, and academic networks. At the same time, the pipeline of specialists isn’t keeping pace with growing patient needs, particularly in complex fields like vascular…

Read More